PRGN-2012 has the potential to be the first- and best-in-class treatment for RRP Company's BLA for PRGN-2012 ... patients outside of the US Precigen Logo (PRNewsfoto/Precigen, Inc.) "We are ...

PRGN-2012 has the potential to be the first- and best-in-class treatment for RRP Company's BLA for PRGN-2012 for the treatment ... and more than 125,000 patients outside of the US Precigen Logo ...

today announced first quarter 2025 financial results and business updates. "We are extremely pleased with the progress of our PRGN-2012 program and its immense potential for RRP patients.